Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02485340Completed
Randomised, double-blind trial in migraine comparing Sumatriptan with Placebo (2 arms). Primary endpoints: Median headache score 0 hours after sumatriptan/placebo and Median headache score 2 hours after sumatriptan/placebo. Started Apr 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02485340.